Vitamin C supplementation lowers serum low-density lipoprotein cholesterol and triglycerides: a meta-analysis of 13 randomized controlled trials

Journal of Chiropractic Medicine

Volumn 7, Issue 2, 2008, Pages 48-58

  McRae, Marc P ^a  

^a NATIONAL UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Ascorbic Acid; Chiropractic; Cholesterol; Meta analysis; Triglycerides; Vitamin C

Indexed keywords

EID: 44149086390     PISSN: 08993467     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcme.2008.01.002     Document Type: Article

References (68)

1. Rosamond W., Flegal K., Friday G., et al. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 5 (2007) e69-e171
2. McRae M.P. Vitamin C supplementation for treating hypercholesterolemia: a meta-analysis of 16 randiomized controlled trials. J Am Nutraceut Ass 10 2 (2007) 21-28
3. Knekt P., Ritz J., Pereira M.A., O'Reilly E.J., Augustsson K., Fraser G.E., et al. Antioxidant vitamins and coronary heart disease risk: a pooled analysis of 9 cohorts. Am J Clin Nutr 80 6 (2004) 1508-1520
4. Abbott R.D., Wilson P.W., Kannel W.B., and Castelli W.P. High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study. Arteriosclerosis 8 3 (1988) 207-211
5. Castelli W.P., Anderson K., Wilson P.W., and Levy D. Lipids and risk of coronary heart disease. The Framingham Study. Ann Epidemiol 2 1-2 (1992) 23-28
6. Corti M.C., Guralnik J.M., Salive M.E., Harris T., Field T.S., Wallace R.B., et al. HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 274 7 (1995) 539-544
7. Assmann G., Schulte H., von Eckardstein A., and Huang Y. High-density lipoprotein cholesterol as a predictor of coronary heart disease risk. The PROCAM experience and pathophysiological implications for reverse cholesterol transport. Atherosclerosis 124 Suppl (1996) S11-S20
8. Després J.P., Lemieux I., Dagenais G.R., Cantin B., and Lamarche B. HDL-cholesterol as a marker of coronary heart disease risk: the Québec cardiovascular study. Atherosclerosis 153 2 (2000) 263-272
9. Franceschini G. Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease. Am J Cardiol 88 12A (2001) 9N-13N
10. Manninen V., Tenkanen L., Koskinen P., et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 85 1 (1992) 37-45
11. Jeppesen J., Hein H.O., Suadicani P., and Gyntelberg F. Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study. Circulation 97 11 (1998) 1029-1036
12. Austin M.A., Hokanson J.E., and Edwards K.L. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 81 4A (1998) 7B-12B
13. Tulenko T.N., and Sumner A.E. The physiology of lipoproteins. J Nucl Cardiol 9 6 (2002) 638-649
14. Brubacher D., Moser U., and Jordan P. Vitamin C concentrations in plasma as a function of intake: a meta-analysis. Int J Vitam Nutr Res 70 5 (2000) 226-237
15. Levine M., Conry-Cantilena C., Wang Y., et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc Natl Acad Sci 93 8 (1996) 3704-3709
16. Horsey J., Livesley B., and Dickerson J.W. Ischaemic heart disease and aged patients: effects of ascorbic acid on lipoproteins. J Hum Nutr 35 1 (1981) 53-58
17. Wahlberg G., and Walldius G. Lack of effect of ascorbic acid on serum lipoprotein concentrations in patients with hypertriglyceridaemia. Atherosclerosis 43 2-3 (1982) 283-288
18. Bishop N., Schorah C.J., and Wales J.K. The effect of vitamin C supplementation on diabetic hyperlipidaemia: a double blind, crossover study. Diabet Med 2 2 (1985) 121-124
19. Aro A., Kyllastinen M., Kostiainen E., Gref C.G., Elfving S., and Uusitalo U. No effect on serum lipids by moderate and high doses of vitamin C in elderly subjects with low plasma ascorbic acid levels. Ann Nutr Metab 32 3 (1988) 133-137
20. Salonen J.T., Salonen R., Seppanen K., et al. Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status. Am J Clin Nutr 53 5 (1991) 1222-1229
21. Cerna O., Ramacsay L., and Ginter E. Plasma lipids, lipoproteins and atherogenic index in men and women administered vitamin C. Cor Vasa 34 3 (1992) 246-254
22. Paolisso G., Balbi V., Volpe C., et al. Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 14 4 (1995) 387-392
23. Gokce N., Keaney J.F., Frei B., et al. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 99 (1999) 3234-3240
24. Fotherby M.D., Williams J.C., Forster L.A., Craner P., and Ferns G.A. Effect of vitamin C on ambulatory blood pressure and plasma lipids in older persons. J Hypertens 18 4 (2000) 411-415
25. Singhal S., Gupta R., and Goyle A. Comparison of antioxidant efficacy of vitamin E, vitamin C, vitamin A and fruits in coronary heart disease: a controlled trial. J Assoc Phys India 49 (2001) 327-331
26. Vinson J.A., and Jang J. In vitro and in vivo lipoprotein antioxidant effect of a citrus extract and ascorbic acid on normal and hypercholesterolemic human subjects. J Med Food 4 4 (2001) 187-192
27. Rezaian G.R., Taheri M., Mozaffari B.E., Mosleh A.A., and Ghalambor M.A. The salutary effects of antioxidant vitamins on the plasma lipids of healthy middle aged-to-elderly individuals: a randomized, double-blind, placebo-controlled study. J Med Liban 50 1-2 (2002) 10-13
28. Shidfar F., Keshavarz A., Jallali M., Miri R., and Eshraghian M. Comparison of the effects of simultaneous administration of vitamin C and omega-3 fatty acids on lipoproteins, apo A-I, apo B, and malondialdehyde in hyperlipidemic patients. Int J Vitam Nutr Res 73 3 (2003) 163-170
29. Follmann D., Elliott P., Suh I., and Cutler J. Variance imputation for overviews of clinical trials with continuous response. J Clin Epidemiol 45 7 (1992) 769-773
30. Jacques P.F., Hartz S.C., McGandy R.B., Jacob R.A., and Russell R.M. Ascorbic acid, HDL, and total plasma cholesterol in the elderly. J Am Coll Nutr 6 2 (1987) 169-174
31. Dallal G.E., Choi E., Jacques P., Schaefer E.J., and Jacob R.A. Ascorbic acid, HDL cholesterol, and apolipoprotein A-I in an elderly Chinese population in Boston. J Am Coll Nutr 8 1 (1989) 69-74
32. Itoh R., Yamada K., Oka J., Echizen H., Suyama Y., and Murakami K. Serum ascorbic acid and HDL cholesterol in a healthy elderly Japanese population. Int J Vitam Nutr Res 60 4 (1990) 360-365
33. Jacques P.F. Effects of vitamin C on high-density lipoprotein cholesterol and blood pressure. J Am Coll Nutr 11 2 (1992) 139-144
34. Hallfrisch J., Singh V.N., Muller D.C., Baldwin H., Bannon M.E., and Andres R. High plasma vitamin C associated with high plasma HDL- and HDL2 cholesterol. Am J Clin Nutr 60 1 (1994) 100-105
35. Joshi V.D., Joshi L.N., and Gokhale L.V. Effect of ascorbic acid on total and high density lipoprotein cholesterol of plasma in normal human subjects. Indian J Physiol Pharmacol 25 4 (1981) 348-350
36. Johnson G.E., and Obenshain S.S. Nonresponsiveness of serum high-density lipoprotein-cholesterol to high dose ascorbic acid administration in normal men. Am J Clin Nutr 34 10 (1981) 2088-2091
37. Sharrett A.R., Ballantyne C.M., Coady S.A., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 104 10 (2001) 1108-1113
38. Parthasarathy S., Barnett J., and Fong L.G. High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044 2 (1990) 275-283
39. Trout D.L. Vitamin C and cardiovascular risk factors. Am J Clin Nutr 53 1 Suppl (1991) 322S-325S
40. Simon J.A. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 11 2 (1992) 107-125
41. Howard P.A., and Meyers D.G. Effect of vitamin C on plasma lipids. Ann Pharmacother 29 11 (1995) 1129-1136
42. Lynch S.M., Gaziano J.M., and Frei B. Ascorbic acid and atherosclerotic cardiovascular disease. Subcell Biochem 25 (1996) 331-367
43. Hemilä H. Vitamin C and plasma cholesterol. Crit Rev Food Sci Nutr 32 1 (1992) 33-57
44. Panagiotakos D.B., Pitsavos C., Skoumas J., et al. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002). Curr Med Res Opin 19 2 (2003) 89-94
45. Jeppesen J., Hein H.O., Suadicani P., and Gyntelberg F. Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 17 6 (1997) 1114-1120
46. Lemieux I., Lamarche B., Couillard C., et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med 161 22 (2001) 2685-2692
47. Polidori M.C., Mecocci P., Levine M., and Frei B. Short-term and long-term vitamin C supplementation in humans dose-dependently increases the resistance of plasma to ex vivo lipid peroxidation. Arch Biochem Biophys 423 1 (2004) 109-115
48. Balkan J., Dogru-Abbasoglu S., Aykac-Toker G., and Uysal M. Serum pro-oxidant-antioxidant balance and low-density lipoprotein oxidation in healthy subjects with different cholesterol levels. Clin Exp Med 3 4 (2004) 237-242
49. Jialal I., Vega G.L., and Grundy S.M. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 82 (1990) 185-191
50. Sakuma N., Yoshikawa M., Hibino A., et al. Ascorbic acid protects against peroxidative modification of low-density lipoprotein, maintaining its recognition by LDL receptors. J Nutr Sci Vitaminol 47 1 (2001) 28-31
51. Montano C.E., Fernandez M.L., and McNamara D.J. Regulation of apolipoprotein B-containing lipoproteins by vitamin C level and dietary fat saturation in guinea pigs. Metabolism 47 7 (1998) 883-891
52. Carr T.P., Parks J.S., and Rudel L.L. Hepatic ACAT activity in African green monkeys is highly correlated to plasma LDL cholesteryl ester enrichment and coronary artery atherosclerosis. Arterioscler Thromb 12 11 (1992) 1274-1283
53. Agellon L.B., Walsh A., Hayek T., et al. Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem 266 17 (1991) 10796-10801
54. Hillstrom R.J., Yacapin-Ammons A.K., and Lynch S.M. Vitamin C inhibits lipid oxidation in human HDL. J Nutr 133 10 (2003) 3047-3051
55. Anantharamaiah G.M., Hughes T.A., Iqbal M., et al. Effect of oxidation on the properties of apolipoproteins A-I and A-II. J Lipid Res 29 3 (1988) 309-318
56. Nagano Y., Arai H., and Kita T. High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification. Proc Natl Acad Sci 88 15 (1991) 6457-6461
57. Jacques P.F., Sulsky S.I., Perrone G.E., Jenner J., and Schaefer E.J. Effect of vitamin C supplementation on lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations. Ann Epidemiol 5 1 (1995) 52-59
58. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assmann G., and von Eckardstein A. HDL and arteriosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161 1 (2002) 1-16
59. Calla M.S., and Lynch S.M. Vitamin C preserves the cardio-protective paraoxonase activity of high-density lipoprotein during oxidant stress. Arch Biochem Biophys 452 2 (2006) 129-137
60. Bobek P., Ginter E., Ozdín L., and Mikus L. The effect of chronic marginal vitamin C deficiency on the rate of secretion and the removal of plasma triglycerides in guinea-pigs. Physiol Bohemoslov 29 4 (1980) 337-343
61. Bobek P., Ginter E., Ozdin L., Poledne R., and Potucek J. Effect of long-term marginal vitamin C deficiency on plasma triglyceride kinetics in guinea-pigs. Biomed Biochim Acta 42 4 (1983) 413-416
62. Gugliucci A., Menini T., and Stahl A.J. Susceptibility to copper-enhanced autoxidation of VLDL+LDL fractions from diabetic patients. Biochem Mol Biol Int 32 1 (1994) 139-147
63. Hasegawa N., Niimi N., and Odani F. Vitamin C is one of the lipolytic substances in green tea. Phytother Res 16 Suppl 1 (2002) S91-S92
64. Ha T.Y., Otsuka M., and Arakawa N. Ascorbate indirectly stimulates fatty acid utilization in primary cultured guinea pig hepatocytes by enhancing carnitine synthesis. J Nutr 124 5 (1994) 732-737
65. Ha T.Y., Otsuka M., and Arakawa N. The effect of graded doses of ascorbic acid on the tissue carnitine and plasma lipid concentrations. J Nutr Sci Vitaminol 36 3 (1990) 227-234
66. Otsuka M., Matsuzawa M., Ha T.Y., and Arakawa N. Contribution of a high dose of l-ascorbic acid to carnitine synthesis in guinea pigs fed high-fat diets. J Nutr Sci Vitaminol 45 2 (1999) 163-171
67. Kothari L.K., Pramod J., Sharma P., and Chaturvedi S.K. Influence of age and vitamin C status on serum cholesterol. Int J Epidemiol 17 4 (1988) 929-930
68. Rivers J.M. Safety of high-level vitamin C ingestion. Int J Vitam Nutr Res Suppl 30 (1989) 95-102